Global Infection Surveillance Solutions Market Size, Share: By Product and Services: Product, Services; By Infection Type: Surgical Site Infection, Urinary Tract Infection, Blood Stream Infection, Others; By End User: Hospitals and Clinics, Ambulatory Surgical Centers, Others; Regional Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Infection Surveillance Solutions Market Overview 
    3.1    Global Infection Surveillance Solutions Market Historical Value (2017-2023) 
    3.2    Global Infection Surveillance Solutions Market Forecast Value (2024-2032)
4    Global Infection Surveillance Solutions Market Landscape
    4.1    Global Infection Surveillance Solutions Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Infection Surveillance Solutions Product Landscape
        4.2.1    Analysis by Product and Services
        4.2.2    Analysis by Infection Type
5    Global Infection Surveillance Solutions Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Infection Surveillance Solutions Market Segmentation 
    6.1    Global Infection Surveillance Solutions Market by Product and Services
        6.1.1    Market Overview
        6.1.2    Product
            6.1.2.1    Software
                6.1.2.1.1    Web/Cloud Based
                6.1.2.1.2    On-premises Based
        6.1.3    Services
            6.1.3.1    Product Support and Maintenance Services
            6.1.3.2    Training and Consulting Services
            6.1.3.3    Implementation Services
            6.1.3.4    Other Services
    6.2    Global Infection Surveillance Solutions Market by Infection Type
        6.2.1    Market Overview
        6.2.2    Surgical Site Infection
        6.2.3    Urinary Tract Infection
        6.2.4    Blood Stream Infection
        6.2.5    Others
    6.3    Global Infection Surveillance Solutions Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals and Clinics
        6.3.3    Ambulatory Surgical Centers
        6.3.4    Specialty Centers
        6.3.5    Long-term Care Facilities
        6.3.6    Others
    6.4    Global Infection Surveillance Solutions Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Infection Surveillance Solutions Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Infection Surveillance Solutions Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Infection Surveillance Solutions Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Infection Surveillance Solutions Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Infection Surveillance Solutions Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Becton, Dickinson and Company
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisition
        17.1.5    Certifications
    17.2    Baxter International Inc.
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisition
        17.2.5    Certifications
    17.3    Wolters Kluwer NV
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisition
        17.3.5    Certifications
    17.4    Premier Inc.
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisition
        17.4.5    Certifications
    17.5    Gojo Industries
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisition
        17.5.5    Certifications
    17.6    BioVigil Healthcare Systems Inc.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisition
        17.6.5    Certifications
    17.7    Medexter Healthcare GmbH
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisition
        17.7.5    Certifications
    17.8    Koninklijke Philips NV
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisition
        17.8.5    Certifications
    17.9    PeraHealth
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisition
        17.9.5    Certifications
    17.10    Deb Group Ltd.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisition
        17.10.5    Certifications
    17.11    Cerner Corporation
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisition
        17.11.5    Certifications
18    Global Infection Surveillance Solutions Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)
    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

*Additional insights provided are customisable as per client requirements.